/PRNewswire/ Molecure S.A. ("Molecure") (WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and.
Our new name "Molecure" reflects expansion of scope of small molecule targets from novel proteins to mRNA in discovery & development of breakthrough therapies.
/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and.